SDX-105
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2291 SDX-105 (Treanda™, bendamustine), an alkylating agent with a distinct mechanism of action, is active in NHL and CLL patients…
SDX-105 (Treanda™) is an alkylating agent with a distinct mechanism of action that has been shown to be active in clinical trials…